Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms × Ketamine × Clear all

Phase

Phase 4 3 Phase NA 2 Phase 2 2 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 5 Neoplasms 5 Pain, Intractable 3 Agnosia 3 Pain, Postoperative 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Spinal Stenosis 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Peripheral Nervous System Diseases 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain, Procedural 1 Neurotoxicity Syndromes 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Mucositis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cyclophosphamide 149 Docetaxel 138 Paclitaxel 127 Trastuzumab 119 Tamoxifen 110 Capecitabine 104 Letrozole 91 Epirubicin 79 Doxorubicin 70 Anastrozole 69 exemestane 66 Fulvestrant 65 Fluorouracil 61 Radiotherapy 59 pertuzumab 40 Gemcitabine 39 Carboplatin 38 Vinorelbine 34 Goserelin 34 Bevacizumab 29 Zoledronic Acid 28 Methotrexate 28 Chemotherapy, Adjuvant 28 eribulin 27 Lapatinib 25 ribociclib 24 palbociclib 24 Drug Therapy 22 130-nm albumin-bound paclitaxel 20 pegfilgrastim 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00210210 2025-09-19

KETAMINE

Institut Bergonié

Phase 3 Completed

230 enrolled 6 charts

Agnosia, Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡